Showing results (21-30 of 142) with videos related to

Sort By:
Pageof 15
The Annals of Pharmacotherapy|January 15, 2010
Medication changes prior to hospitalization for obstructive lung disease: a case-crossover studyKarin J Velthove, Hubert Gm Leufkens, René C Schweizer, et al.
Emerging Themes in Epidemiology|May 18, 2010
Testing bias in clinical databases: methodological considerationsKarin J Velthove, Hubert Gm Leufkens, Patrick C Souverein, et al.
Frontiers in Physiology|June 19, 2018
Squeezing for Life - Properties of Red Blood Cell DeformabilityRick Huisjes, Anna Bogdanova, Wouter W van Solinge, et al.
International Journal of Nanomedicine|May 24, 2012
Exosome mimetics: a novel class of drug delivery systemsSander A A Kooijmans, Pieter Vader, Susan M van Dommelen, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 16, 2003
Molecular basis of congenital afibrinogenaemia in a Dutch familyJasper A Remijn, Richard van Wijk, H Karel Nieuwenhuis, et al.
European Journal of Clinical Pharmacology|March 23, 2011
Frequency of laboratory measurement and hyperkalaemia in hospitalised patients using serum potassium concentration increasing drugsEsther V Uijtendaal, Jeannette E F Zwart-van Rijkom, Wouter W van Solinge, et al.
The Annals of Pharmacotherapy|February 3, 2012
Serum potassium influencing interacting drugs: risk-modifying strategies also needed at discontinuationEsther V Uijtendaal, Jeannette E F Zwart-van Rijkom, Wouter W van Solinge, et al.
British Journal of Haematology|April 3, 2004
Ex vivo analysis of aberrant splicing induced by two donor site mutations in PKLR of a patient with severe pyruvate kinase deficiencyRichard Wijk, Annet C W van Wesel, Adri A M Thomas, et al.
Blood Cells, Molecules & Diseases|April 28, 2007
Characterization of the -16C>G sequence variation in the promoters of both HBG1 and HBG2: convergent evolution of the human gamma-globin genesKaren M K de Vooght, Richard van Wijk, Hans K Ploos van Amstel, et al.
The Journal of Applied Laboratory Medicine|October 23, 2019
Osteoprotegerin is Higher in Sepsis Than in Noninfectious SIRS and Predicts 30-Day Mortality of SIRS Patients in the Intensive CareHans Kemperman, Irene T Schrijver, Mark Roest, et al.
Pageof 15